Find an Article

Filter articles

Applied Filters

Showing 41 to 50 of 287 results

USITC: a powerful forum for biologics patent owners

US10-10-2018Filko Prugo, Charlotte Jacobsen, Matt Rizzolo and Henry Huang

Biologics patent owners should consider the US International Trade Commission as a supplement (or alternative) to district court litigation, say Filko Prugo, Charlotte Jacobsen, Matt Rizzolo and Henry Huang of Ropes & Gray.

Conference preview: Life Sciences IP Due Diligence 2018


A former Johnson & Johnson IP counsel and a retired judge are among the speakers at Life Sciences IP Due Diligence, on November 29 and 30 in Boston, as LSIPR finds out.

Arrow declarations: which way is the law pointing?

UK08-10-2018David Holt and Tony Proctor

Depending on the facts and the content of the applications, an Arrow-type declaration could be made on grounds of insufficiency against divisional applications, say David Holt and Tony Proctor of Potter Clarkson.

IP and personalised medicine: a tailor-made approach


While personalised medicine is a challenging area for drug developers, there are a number of potential solutions, as LSIPR finds out.

3Scan’s Nada Rastad: crossing the line and patenting robotics


American biotech 3Scan is combining robotics with machine learning and automation to offer microscopy services for the 3D analysis of cells, tissues, and organs. LSIPR met general counsel Nada Rastad to hear about some of the patenting challenges.

CRISPR patents: guidance from US courts

US19-09-2018Pat Carson and Mira Atanassova Mulvaney

Several recent cases from the US Court of Appeals for the Federal Circuit offer guidance on navigating the §101 legal framework with respect to CRISPR patent claims, as Pat Carson and Mira Atanassova Mulvaney of Kirkland & Ellis report.

Patenting polymorphs in Mexico

Mexico11-09-2018Lino Almazan-Monroy and Mariana Gonzalez-Vargas

Lino Almazan-Monroy and Mariana Gonzalez-Vargas of Becerril, Coca & Becerril discuss how inventors seeking patents for polymorphs in Mexico can give themselves the best chance of success.

Mexico’s patent linkage system: current state, effects and flaws

Mexico06-09-2018Mariana Gonzalez-Vargas and Hector Chagoya

A well-functioning linkage system for patents and drugs allows healthcare and patent authorities to maximise the impact of innovation, say Hector Chagoya and Mariana Gonzalez-Vargas of Becerril, Coca & Becerril, who report on the Mexican landscape.

Patenting microorganisms in Mexico

Mexico05-09-2018Mariana Gonzalez-Vargas

Mexico has international depositary authority (IDA) status under the Budapest Treaty, which speeds up the patent process for microorganisms. Mariana Gonzalez-Vargas of Becerril, Coca & Becerril reviews the impact of the IDA on biotech patents in the country.

LSIPR 50 2018: Christopher Viehbacher


Christopher Viehbacher was selected in the LSIPR 50 2018 publication for​ ​his influence on the life sciences industry. He featured in the investment section, as LSIPR reports.

Showing 41 to 50 of 287 results